{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:50:04Z","timestamp":1792158604286,"version":"4.4.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,6,8]],"date-time":"2015-06-08T00:00:00Z","timestamp":1433721600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,6,8]],"date-time":"2015-06-08T00:00:00Z","timestamp":1433721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1038\/bmt.2015.120","type":"journal-article","created":{"date-parts":[[2015,6,8]],"date-time":"2015-06-08T15:14:16Z","timestamp":1433776456000},"page":"1250-1252","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Imatinib for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1038","volume":"50","author":[{"given":"S","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Waseda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Takato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Ohata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,8]]},"reference":[{"key":"BFbmt2015120_CR1","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1056\/NEJMra1204664","volume":"370","author":"AF Barker","year":"2014","unstructured":"Barker AF, Bergeron A, Rom WN, Hertz MI . Obliterative bronchiolitis. N Engl J Med 2014; 370: 1820\u20131828.","journal-title":"N Engl J Med"},{"key":"BFbmt2015120_CR2","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1001\/jama.2009.1018","volume":"302","author":"KM Williams","year":"2009","unstructured":"Williams KM, Chien JW, Gladwin MT, Pavletic SZ . Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. JAMA 2009; 302: 306\u2013314.","journal-title":"JAMA"},{"key":"BFbmt2015120_CR3","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1183\/09031936.00052806","volume":"29","author":"AO Soubani","year":"2007","unstructured":"Soubani AO, Uberti JP . Bronchiolitis obliterans following haematopoietic stem cell transplantation. Eur Respir J 2007; 29: 1007\u20131019.","journal-title":"Eur Respir J"},{"key":"BFbmt2015120_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1756-8722-3-47","volume":"3","author":"G Wei","year":"2010","unstructured":"Wei G, Rafiyath S, Liu D . First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib. J Hematol Oncol 2010; 3: 47.","journal-title":"J Hematol Oncol"},{"key":"BFbmt2015120_CR5","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.bbmt.2006.03.008","volume":"12","author":"NS Majhail","year":"2006","unstructured":"Majhail NS, Schiffer CA, Weisdorf DJ . Improvement of pulmonary function with imatinib mesylate in bronchiolitis obliterans following allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2006; 12: 789\u2013791.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2015120_CR6","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1182\/blood-2009-02-204156","volume":"114","author":"A Olivieri","year":"2009","unstructured":"Olivieri A, Locatelli F, Zecca M, Sanna A, Cimminiello M, Raimondi R et al. Imatinib for refractory chronic graft-versus-host disease with fibrotic features. Blood 2009; 114: 709\u2013718.","journal-title":"Blood"},{"key":"BFbmt2015120_CR7","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.1182\/blood-2013-05-494278","volume":"122","author":"A Olivieri","year":"2013","unstructured":"Olivieri A, Cimminiello M, Corradini P, Mordini N, Fedele R, Selleri C et al. Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD. Blood 2013; 122: 4111\u20134118.","journal-title":"Blood"},{"key":"BFbmt2015120_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.bbmt.2013.11.025","volume":"20","author":"J Palmer","year":"2014","unstructured":"Palmer J, Williams K, Inamoto Y, Chai X, Martin PJ, Tomas LS et al. Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease. Biol Blood Marrow Transplant 2014; 20: 337\u2013344.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2015120_CR9","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","volume":"11","author":"AH Filipovich","year":"2005","unstructured":"Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945\u2013956.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2015120_CR10","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.1182\/blood-2009-07-231159","volume":"114","author":"M Stadler","year":"2009","unstructured":"Stadler M, Ahlborn R, Kamal H, Diedrich H, Buchholz S, Eder M et al. Limited efficacy of imatinib in severe pulmonary chronic graft-versus-host disease. Blood 2009; 114: 3718\u20133719 author reply 3719-3720.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2015120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2015120","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2015120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T18:16:26Z","timestamp":1648059386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2015120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,8]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["BFbmt2015120"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2015.120","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,8]]},"assertion":[{"value":"8 June 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}